MLL-ELL fusion gene in two infants with acute monoblastic leukemia and myeloid sarcoma. 2012

Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015514 Oncogene Proteins, Fusion The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin. Chimeric Oncogene Proteins,Chimeric Proteins, Oncogene,Fusion Proteins, Oncogene,Oncogene Fusion Proteins,Oncogene Proteins, Chimeric,Fusion Oncogene Proteins,Oncogene Chimeric Proteins,Proteins, Chimeric Oncogene,Proteins, Fusion Oncogene,Proteins, Oncogene Chimeric,Proteins, Oncogene Fusion
D017668 Age of Onset The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age-at-Onset,Age at Onset,Onset Age
D051788 Myeloid-Lymphoid Leukemia Protein Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS. Acute Lymphoblastic Leukemia Protein 1,MLL Proto-Oncogene Protein,Mixed-Lineage Leukemia Protein,Proto-Oncogene Proteins MLL,Zinc Finger Protein HRX,MLL Proto Oncogene Protein,MLL, Proto-Oncogene Proteins,Mixed Lineage Leukemia Protein,Myeloid Lymphoid Leukemia Protein,Proto Oncogene Proteins MLL,Proto-Oncogene Protein, MLL
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
January 2015, Experimental hematology & oncology,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
June 2015, Clinical case reports,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
March 2015, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
December 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
March 2019, Diagnostic pathology,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
June 2011, British journal of haematology,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
September 2010, Cancer genetics and cytogenetics,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
September 2009, American journal of hematology,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
July 2008, Cancer genetics and cytogenetics,
Etienne De Braekeleer, and Nathalie Douet-Guilbert, and Claus Meyer, and Frédéric Morel, and Rolf Marschalek, and Marc De Braekeleer
March 2001, Cancer research,
Copied contents to your clipboard!